Cargando…

The assessment of platelet function by thromboelastometry as a point‐of‐care test to guide Intercept‐treated platelet support in hemato‐oncological patients and hematopoietic stem cell transplantation recipients

BACKGROUND: Pathogen inactivation (PI) techniques for platelet concentrates (PCs) are one of the latest innovations to improve blood safety and reduce the risk of transfusion‐transmitted infections (TTIs). An impaired function and in vivo recovery of platelets as well as an increased PC demand are c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leitner, Gerda C., Ho, Markus, Tolios, Alexander, Hopfinger, Georg, Rabitsch, Werner, Wohlfarth, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Transfusion Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497158/ https://www.ncbi.nlm.nih.gov/pubmed/32319678 http://dx.doi.org/10.1111/trf.15783

Ejemplares similares

Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)

INTERCEPT Pathogen Reduction in Platelet Concentrates, in Contrast to Gamma Irradiation, Induces the Formation of trans-Arachidonic Acids and Affects Eicosanoid Release during Storage
por: Leitner, Gerda C., et al.
Publicado: (2022)

Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019)

Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
por: Razjou, Farhad, et al.
Publicado: (2017)

Cost implications of implementation of pathogen-inactivated platelets
por: McCullough, Jeffrey, et al.
Publicado: (2015)

Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019)

Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
por: Snyder, Edward L., et al.
Publicado: (2022)

Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice
por: Couvidou, Adèle, et al.
Publicado: (2022)

Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
por: Infanti, Laura, et al.
Publicado: (2019)

Phased implementation of pathogen‐reduced platelets in a health system facilitates increased manufacturing at the blood center
por: Allen, Elizabeth S., et al.
Publicado: (2019)

Individual Variation in Growth Factor Concentrations in Platelet-rich Plasma and Its Influence on Human Mesenchymal Stem Cells
por: Cho, Hee Soon, et al.
Publicado: (2011)

Aged versus fresh autologous platelet transfusion in a two‐hit healthy volunteer model of transfusion‐related acute lung injury
por: van Baarle, Floor L. F., et al.
Publicado: (2022)

Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions
por: van Osch, Thijs L. J., et al.
Publicado: (2022)

Does the evidence support the importance of high transfusion ratios of plasma and platelets to red blood cells in improving outcomes in severely injured patients: a systematic review and meta‐analyses
por: da Luz, Luis Teodoro, et al.
Publicado: (2019)

Inhibition of GPIb-α-mediated apoptosis signaling enables cold storage of platelets
por: Marini, Irene, et al.
Publicado: (2023)

Thromboelastometry and Platelet Function during Acclimatization to High Altitude
por: Rocke, Alistair S., et al.
Publicado: (2018)

Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography
por: Solomon, Cristina, et al.
Publicado: (2015)

Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients
por: Alshalani, Abdulrahman, et al.
Publicado: (2022)

Erratum to: Thromboelastometry and platelet function during acclimatisation to high altitude
por: Rocke, Alistair S., et al.
Publicado: (2018)

Stem Cells in Hemato-Oncology
por: Damodar, S
Publicado: (2006)

Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury
por: Bayat, Behnaz, et al.
Publicado: (2021)

Prevalence of risk factors for platelet transfusion refractoriness in multitransfused hemato-oncological patients at tertiary care center in North India
por: Kumawat, Vijay, et al.
Publicado: (2015)

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn
por: Kapur, Rick, et al.
Publicado: (2014)

Association between maternal haemoglobin and stillbirth: a cohort study among a multi‐ethnic population in England
por: Nair, Manisha, et al.
Publicado: (2017)

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019)

The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion‐induced red blood cell alloimmunisation
por: Oud, Josine A., et al.
Publicado: (2021)

International guidelines regarding the role of IVIG in the management of Rh‐ and ABO‐mediated haemolytic disease of the newborn
por: Lieberman, Lani, et al.
Publicado: (2022)

Intervening on the storage time of RBC units and its effects on adverse recipient outcomes using real-world data
por: Bruun-Rasmussen, Peter, et al.
Publicado: (2022)

Cryopreserved platelets compared with liquid-stored platelets for the treatment of surgical bleeding: protocol for two multicentre randomised controlled blinded non-inferiority trials (the CLIP-II and CLIPNZ-II trials)
por: Reade, Michael C., et al.
Publicado: (2022)

Impact of cold storage on platelets treated with Intercept pathogen inactivation
por: Six, Katrijn R., et al.
Publicado: (2019)

Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study
por: Tay, Jason, et al.
Publicado: (2016)

Assay validity of point-of-care platelet function tests in thrombocytopenic blood samples
por: Lacom, Conrad, et al.
Publicado: (2022)

Evaluation of bacterial inactivation in random donor platelets and single-donor apheresis platelets by the INTERCEPT blood system
por: Makroo, Raj Nath, et al.
Publicado: (2018)

Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen– and antibody to hepatitis B core antigen–positive donor
por: Blaich, Annette, et al.
Publicado: (2012)

PRES in the course of hemato-oncological treatment in children
por: Musioł, Katarzyna, et al.
Publicado: (2017)

Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients
por: Caldwell, Louise, et al.
Publicado: (2022)

Prediction of Mid-term Platelet Transfusion in Stable Trauma Patients Using Rotational Thromboelastometry
por: Lim, Ha Jin, et al.
Publicado: (2024)

Palestinian Children in the Hemato-Oncology Ward of an Israeli Hospital
por: Nehari, Miri, et al.
Publicado: (2008)

Monitoring of the Environment at the Transplant Unit—Hemato-Oncology Clinic
por: Matoušková, Ivanka, et al.
Publicado: (2014)

Hemato-oncology Tourism in Israel: A Retrospective Review
por: Hod, Keren, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_37arboat43os4ufqlhh68jr57n